Prognostic value of cell-cycle regulators and cellular biomarkers in laryngeal squamous cell carcinoma

Clinical Biochemistry

Volumn 41, Issue 13, 2008, Pages 1059-1066

  Swellam, Menha ^a   El Arab, Lobna R Ezz ^b   Adly, Ahmed ^c  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Ear Nose and Throat Department   (Egypt)

Author keywords

Carcinogenesis; Laryngeal squamous cell carcinoma; Prognostic factors; Telomerase; Tumor suppressor genes

Indexed keywords

CISPLATIN DERIVATIVE; COBALT 60; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA; TELOMERASE;

ANEUPLOIDY; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL CYCLE REGULATION; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; GENE DELETION; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 49549124484     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.06.001     Document Type: Article

References (36)

1. Reshmi S.C., and Gollin S.M. Chromosomal instability in oral cancer cells. J Dent Res 84 (2005) 107-117
2. Todd R., Hinds P.W., Munger K., et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol 13 (2002) 51-61
3. Zingde S.M. Cancer genes. Current Science 81 (2001) 508-514
4. Michalides R.J. Cell cycle regulators: mechanisms and their role in etiology, prognosis, and treatment of cancer. J Clin Pathol 52 (1999) 555-568
5. Danahey D.G., Tobin E.J., Schuller D.E., Bier-Laning C.M., Weghorst C.M., and Lang J.C. P16 mutation frequency and clinical correlation in head and neck cancer. Acta Oto-Laryngologica 19 (2004) 285-288
6. Sanchez-Cespedes M., Esteller M., Wu L., et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60 (2000) 892-895
7. El-Naggar A.K., Lai S., Clayman G.L., et al. Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. Hum Pathol 30 (1999) 1013-1018
8. Partridge M., Gaballah K., and Huang X. Molecular markers for diagnosis and prognosis. Cancer and Metastasis Reviews 24 (2005) 71-85
9. Dahlgren L., Mellin H., Wangsa D., et al. Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papilloma virus-positive and -negative tumors. Int J Cancer 107 (2003) 244-249
10. Liao C.T., Chang T.J., Wang H.M., et al. Telomerase as independent prognostic factor in head and neck squamous cell carcinoma. Head and Neck 26 (2004) 504-512
11. Fiedler W., Hoppe C., Schimmel B., et al. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers. Int J Mol Med 9 (2002) 417-423
12. Hess J.L., and Highsmith W.E.J. Telomerase detection in body fluids. Clin Chem 48 (2002) 18-24
13. Mitelman F., Johansson B., and Mertens F. Mitelman database of chromosome aberrations in cancer (2004). http://www.cgap.nci.nih.gov/hromosomes.mitelman Available from http//cgap.nci.nih.gov/hromosomes.mitelman
14. Tsao A.S., Kim E.S., and Hong W.K. Chemoprevention of cancer. CA Cancer J Clin 54 (2004) 150-180
15. In: Sobin L.H., and Wittekind C.h. (Eds). TNM classification of malignant tumors. 5th ed. (1997), John Wiley & Sons, Inc, New York
16. World Health Organization. International histological classification of tumors. 2nd ed. Geneva: World Health Organization, 1969-1981; Berlin: Springer-Verlag.
17. Eissa S., Khalifa A., Laban M., Elian A., and Bolton W.E. Comparison of flow cytometric DNA content analysis in fresh and paraffin embedded ovarian neoplasms: a prospective study. Br J Cancer 77 (1998) 421-425
18. Heldley D.W., Friedlander M.L., Taylor I.W., Rugg C.A., and Musgrove E.A. Methods for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J Histochem Cytochem 31 (1983) 1333-1335
19. Jakson D.P., Hayden J.D., and Quirke P. Extraction of nucleic acid from fresh and archival material. In: Mcpherson M.J., Quirke P., and Taor G.R. (Eds). PCR: a practical approach (1998), Oxford Univ. Press 29-49
20. Lang J.C., Borchers J., Danahey D., et al. Mutational status of overexpressed p16 in head and neck cancer: evidence for germ line mutation of p16/p14ARF. Int J Oncol 21 (2002) 401-408
21. Latres E., Malumbres M., Sotillo R., et al. Limited overlapping roles of P15 (INK4b) and P18 (INK4c) cell cycles inhibitors in proliferations and tumorigenesis. Embo J 19 (2000) 3496-3506
22. Eissa S., and Seada L. Quantitation of Bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with western blot and immunohistochemistry. Clin Chem 44 (1999) 1423-1429
23. Bradford M.M.A. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
24. Kim N.W., Piatyszek M.A., and Prowse K.R. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
25. Wright W.E., Shay J.W., and Piatyszek M.A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23 (1995) 3794-3795
26. Zweig M.H., and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39 (1993) 561-577
27. Myers J.N. Factors in head and neck cancer: what the radiologist needs to know about angiogenesis, epidermal growth factors, and just what is p53?. ASNR 14 (2005) 9-14
28. Duan J., Chen Z., Liu P., Zhang Z., and Tong T. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells. Int J Oncol 24 (2004) 1597-1605
29. Shintani S., Nakahara Y., Mihara M., Ueyama Y., and Matsumura T. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol 37 (2001) 498-504
30. Swellam M., Abdel El-Aal A.A., and Abu-Gabel K.M. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-expression. Clin Biochm 37 (2004) 1098-1104
31. Fuxe J., Ausjarvi G., Goike H.M., et al. Adenovirus mediated overexpression of p15INK4b inhibits human glioma cell growth induces replicative senescence and inhibits telomerase activity similarly to p16 INK4a. Cell growth & Diff 11 (2000) 373-384
32. Hahn W.C. Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 21 (2003) 2034-2043
33. Amar A., Franzi S.A., and Rapoport A. Evaluation of patients with squamous cell carcinoma of upper aero-digestive tract. Sao Paulo Med J 12 (2003) 155-158
34. EL-Sayed Y.A., and Sausville E.A. Selected novel anticancer treatments targeting cell signaling proteins. The Oncologist 6 (2001) 517-537
35. McNeish I.A., Bell S.J., and Lemoine N.R. Gene therapy progress and prospects: cancer gene therapy using tumor suppressor genes. Gene Therapy 11 (2004) 497-503
36. Keith W.N., Bilsland A., Evans T.R.J., and Glasspool R.M. Telomerase-mediated molecular therapeutics. Expert reviews in molecular medicine. http://www.expertreviews.org